BRITTANY BARON: Open Payments
NPI 1881176881 · LANGHORNE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 25 payments from 11 companies in 2025. Trend: 2023 $1,225 · 2024 $400 · 2025 $561
Food & beverage: $467Education: $94
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $158 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| ABBVIE INC. | 4 | $70 |
| Exeltis, USA Inc. | 3 | $60 |
| MILLICENT US INC | 2 | $45 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $34 |
| Sage Therapeutics, LLC | 1 | $32 |
| Hologic Sales and Service, LLC | 1 | $29 |
| PFIZER INC. | 1 | $22 |
| CooperSurgical, Inc. | 1 | $20 |
Products named: LILETTA, Veozah, SLYND, GEMTESA, INTRAROSA, ZURZUVAE, APTIMA, ABRYSVO.
Industry payments across PA — which companies pay providers there.
